54. Adult still disease Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 25 / Drugs : 32 - (DrugBank : 16) / Drug target genes : 16 - Drug target pathways : 99
Adult still disease and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
ID | Diseases (Sorted by score) | Score |
---|---|---|
54 | Adult still disease | - |
13 | Multiple sclerosis | 1.000 |
2 | Amyotrophic lateral sclerosis | 1.000 |
46 | Malignant rheumatoid arthritis | 1.000 |
49 | Systemic lupus erythematosus | 1.000 |
51 | Scleroderma | 1.000 |
84 | Sarcoidosis | 1.000 |
86 | Pulmonary arterial hypertension | 1.000 |
331 | Idiopathic multicentric castleman disease | 1.000 |
53 | Sjogren syndrome | 1.000 |
271 | Ankylosing spondylitis | 1.000 |
50 | Dermatomyositis | 1.000 |
56 | Behcet disease | 1.000 |
107 | Juvenile idiopathic arthritis | 1.000 |
40 | Takayasu arteritis | 1.000 |
41 | Giant cell arteritis | 1.000 |
42 | Polyarteritis nodosa | 1.000 |
43 | Microscopic polyangiitis | 1.000 |
55 | Relapsing polychondritis | 1.000 |
11 | Myasthenia gravis | 1.000 |
44 | Wegener granulomatosis | 1.000 |
266 | Familial mediterranean fever | 1.000 |